SMO and metabolic dysfunction-associated steatohepatitis: Furthermore, Smo negatively correlated with serum AST, NASH activity score, and hepatocyte ballooning scores (Figure 11B–D), linking Smo loss to increased severity of lipotoxic liver injury.